Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-328454
Filing Date
2026-07-31
Accepted
2026-07-31 16:04:04
Documents
67
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fblg-20260630.htm   iXBRL 10-Q 2074261
2 EX-10.7 fblg-ex10_7.htm EX-10.7 20660
3 EX-31.1 fblg-ex31_1.htm EX-31.1 16418
4 EX-31.2 fblg-ex31_2.htm EX-31.2 16364
5 EX-32.1 fblg-ex32_1.htm EX-32.1 7815
  Complete submission text file 0001193125-26-328454.txt   7731590

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fblg-20260630.xsd EX-101.SCH 965560
71 EXTRACTED XBRL INSTANCE DOCUMENT fblg-20260630_htm.xml XML 1242213
Mailing Address 9350 KIRBY DRIVE SUITE 300 HOUSTON TX 77054
Business Address 9350 KIRBY DRIVE SUITE 300 HOUSTON TX 77054 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41934 | Film No.: 261228398
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)